By Godgift Harris
The Liberia Medicines and Health Products Regulatory Authority (LMHRA), has announced sweeping reforms, which unearthed about 641 tons of ‘expired drugs.’
The reforms aimed at strengthening the country pharmaceutical regulatory system, enhancing drug quality, and restoring public confidence in health products on the market.
LMHRA Managing Director, Dr. Luke L. Bawo, made the disclosure when he appeared at the Ministry of Information regular press briefing on Thursday, November 27, 2025.
Bawo outlined the Authority’s achievements over the past year.
He unveiled new initiatives intended to modernize the entity, and ensure safer health products for the public.
Dr. Bawo reminded Liberians that LMHRA’s foremost mandate is to protect the population from the dangers of substandard and falsified medicines.
While acknowledging gains in diagnostic services, supply chain management, and health workforce training, he said the quality of health products remains a major national challenge.
“People seek treatment, and follow medical protocols, but do not recover.”
Bawo cited cases of medicines with incorrect strength, and products containing undisclosed active ingredients.
One example referenced was the controversial Koko Forte, which was found to contain amphetamine.
“A health system is only as strong as the quality of the health products in circulation.”
Among the entity’s most notable achievements, is a nationwide cleanup of expired, and unsafe medical products.
In partnership with the World Bank and Chemonics, LMHRA successfully removed, and safely disposed of 641.88 tons of expired health products from facilities in 10 of the 15 counties.
The cleanup included major institutions such as the JFK Medical Center, Redemption Hospital and the Central Medicine Store.
The volume of waste collected is equivalent to 65 truckloads, with operations expected to extend to the remaining southeastern counties in the coming months.
Dr. Bawo further disclosed significant progress toward achieving global regulatory standards.
Its newly established Quality Control Unit is working toward attaining WHO Maturity Level 3, which would certify Liberia as having a functional and internationally credible regulatory authority.
Additionally, the entity is pushing for ISO 17025 certification for its national laboratory an accreditation that would validate the lab’s competence in pharmaceutical testing and strengthen Liberia’s position in ensuring drug quality.
In a move to upgrade national pharmaceutical testing capacity, Dr. Bawo announced that LMHRA has entered a Public-Private Partnership (PPP) with Quality Management Solutions (QMS) to modernize the Quality Control Laboratory.
The collaboration is considered a major milestone that will enhance regulatory oversight and ensure more accurate drug analysis.
The LMHRA disclosed plans to inaugurate a new state-of-the-art health care waste disposal facility located on a five-acre site in Koko Town, Lower Margibi County.
Funded by the Global Fund through Plan-Liberia, the facility featuring a high-capacity self-loading incinerator and warehouse is expected to be commissioned by December 31.
Once operational, the facility will safely handle the disposal of expired drugs, illicit pharmaceuticals, pathological waste, and other hazardous materials.
The Ministry of Health has agreed to electrify the site, while the Ministry of Public Works, has begun grading the six-mile access road leading to the facility.
LMHRA currently operates mainly in Montserrado, Grand Cape Mount, Margibi and Nimba counties, but Dr. Bawo said the expansion is essential to fully enforce pharmaceutical regulations nationwide.